Outpatient COVID therapy linked to 88% lower odds of severe outcomes in AIRD patients

Patients with autoimmune rheumatic disease who receive outpatient therapy are 88% less likely to develop severe COVID-19 outcomes vs. with those who do not undergo outpatient therapy, according to data published in The Lancet Rheumatology.

Read the full article here

Related Articles